SPRTN Protease and Checkpoint Kinase 1 Cross-Activation Loop Safeguards DNA Replication

Halder, S.; Torrecilla, I.; Burkhalter, M.; Popovic, M.; Fielden, J.; Vaz, B.; Oehler, J.; Pilger, D.; Lessel, D.; Wiseman, K.; Singh, A. N.; Vendrell, I.; Fischer, R.; Philipp, M.; Ramadan, K.

doi:10.1101/458026

bioRxiv · 10.1101/458026

SPRTN Protease and Checkpoint Kinase 1 Cross-Activation Loop Safeguards DNA Replication

Halder, S.·Torrecilla, I.·Burkhalter, M.·Popovic, M.·Fielden, J.·Vaz, B.·Oehler, J.·Pilger, D.·Lessel, D.·Wiseman, K.·Singh, A. N.·Vendrell, I.·Fischer, R.·Philipp, M.·Ramadan, K.

View original source ↗Export metadata ↓

Abstract

The SPRTN metalloprotease is essential for DNA-protein crosslink (DPC) repair and DNA replication in vertebrate cells. Cells deficient in SPRTN protease activity exhibit severe DPC-induced replication stress and genome instability, manifesting as premature ageing and liver cancer in humans and mice. Strikingly, SPRTN-deficient cells also show a severe G2/M checkpoint defect and fail to activate a robust checkpoint kinase 1 (CHK1) signalling cascade normally triggered in response to replication stress. Here, we show that SPRTN activates the CHK1 signalling cascade during physiological (steady-state) DNA replication by proteolysis-dependent eviction of CHK1 from chromatin. The N-terminal CHK1 fragments cleaved by SPRTN protease still possess kinase activity and phosphorylate SPRTN. This CHK1-dependent phosphorylation stimulates SPRTN recruitment to chromatin to further promote CHK1 eviction from chromatin, DPC removal and unperturbed DNA replication. Our data suggest that a SPRTN-CHK1 cross-activation loop is essential for steady-state DNA replication and protection from DNA replication stress, a major source of genome instability in diseases that cause premature ageing and cancer. In addition, we disclose a mechanism of CHK1 activation during physiological DNA replication, when long stretches of single stranded (ss) DNA that are induced by genotoxic stress and activate canonical and robust CHK1 signalling are not present.

Source connections

Published article ↗

Explore related subjects

cell biology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Halder, S., Torrecilla, I., Burkhalter, M., Popovic, M., Fielden, J., Vaz, B., Oehler, J., Pilger, D., Lessel, D., Wiseman, K., Singh, A. N., Vendrell, I., Fischer, R., Philipp, M., Ramadan, K.. 2018-10-31. SPRTN Protease and Checkpoint Kinase 1 Cross-Activation Loop Safeguards DNA Replication. https://doi.org/10.1101/458026

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Platycodin D2 Targets Vimentin to Suppress Fibroblast-Myofibroblast Transition: A Novel Therapeutic Strategy Against Pulmonary Fibrosis

Background Pulmonary fibrosis is a progressive lung disease characterized by excessive extracellular matrix deposition and irreversible decline in lung function with limited effective therapeutic targets. Vimentin, a type III intermediate filament protein, plays a critical role in fibroblast activation and fibrogenesis, representing a promising drug target. Methods Novel vimentin ligands were screened via virtual screening. SPR assay verified compound-vimentin binding affinity. CETSA and CD spectroscopy analyzed protein structural changes after compound binding. In vitro FMT model and in vivo bleomycin-induced pulmonary fibrosis model were used to assess antifibrotic effects, and mutagenesis assays identified key binding amino acid residues. Results Platycodin D2 (PD2) from Platycodon grandiflorus was identified as a novel high-affinity vimentin ligand (Kd = 392.8 nM). PD2 binds vimentin directly, alters its secondary structure and induces insoluble aggregation. It effectively inhibits TGF-{beta}1-induced FMT in vitro and mitigates bleomycin-induced pulmonary fibrosis in vivo, reducing collagen deposition and improving animal survival. Critically, mutagenesis validation confirmed that key residues (Glu138 in chain A, Glu132 and Glu143 in chain B, as well as Glu50 and Arg54 in chain C) are essential for this interaction. Conclusions Our findings establish PD2 as a novel pharmacological inducer of aberrant vimentin aggregation, presenting a distinct target-driven strategy for antifibrotic drug development.

cell biology↗

bioRxiv2026

Receptor-proximal phosphoform organization precedes β2 integrin activation

Receptor signaling is often framed as protein recruitment after stimulation, but whether receptor-proximal environments are organized in composition and phosphorylation state beforehand remains unclear. We used CD18-APEX2 proximity labeling and a spatial membrane reference to quantify proteins and phosphosites near leukocyte {beta}2 integrins. At rest, receptors, adaptors and Rap GTPases were preferentially represented relative to several catalytic classes. Parent-protein correction revealed spatial phosphoform organization, with 32% of 4,564 phosphosites deviating significantly from the distribution center and 56% of proteins with multiple quantified sites showing divergence beyond measurement error. Sustained activation altered 31% of phosphosites while 95.9% of proteins remained equivalent within {+/-}0.5 log2 and spatial phosphoform organization largely persisted. Most phosphorylation responses were shared across both labeling environments, whereas receptor-preferential changes were dominated by phosphosites. These findings suggest that receptor signaling can regulate pre-existing molecular states without extensive protein redistribution.

cell biology↗

bioRxiv2026

Diversification of budding yeast polarization dynamics after compensatory experimental evolution

Essential cellular processes evolve under strong selection, yet protein networks underlying conserved functions can vary substantially. To what extent evolution constrains the intracellular dynamics of proteins performing essential functions is currently largely unknown. Here, we characterize budding yeast polarization phenotypes along a previously established evolutionary recovery trajectory, compensating for the loss of near-essential polarity gene BEM1. Through quantitative live cell imaging, we show that loss of BEM1 weakens and destabilizes polarization. Surprisingly, in recovered evolved lineages, protein dynamics change significantly compared to the ancestor: most notably, presence of main regulator Cdc42-GTP is strongly decreased, while polarisome member Spa2 localizes more slowly into mobile foci. Although separate phenotypic characteristics are only weakly constrained, we find evidence of effective protein-independent localization modes, revealing signs of convergence along the evolutionary trajectory. Together, our results show that evolution can restore global cellular function without conserving microscopic organization, instead giving rise to novel molecular phenotypes.

cell biology↗